Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 12/2007

01.12.2007 | Short Communication

Non-invasive grading of brain tumours using dynamic amino acid PET imaging : does it work for 11C-Methionine?

verfasst von: Gérard Moulin-Romsée, Eduard D’Hondt, Tjibbe de Groot, Jan Goffin, Raf Sciot, Luc Mortelmans, Johan Menten, Guy Bormans, Koen Van Laere

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Abstract

Background

Static imaging of amino acids does not allow differentiation of low versus high grade brain tumours. It has been shown that dynamic imaging of the amino acid analogue 18F-fluoroethyltyrosine (FET) can achieve this goal. In many centres, 11C-methionine (MET) is used for tumour imaging, but no clinical studies on the use of dynamic scanning for grading have been performed.

Methods

Thirty-four patients with primary brain glioma and histopathological confirmation were retrospectively studied using 40 min dynamic MET–PET with 220 MBq 11C-methionine. In relation to histopathological grading, various metabolic indices and temporal parameters as documented by Poepperl et al. (JNM 2006;47:393–403) were analyzed.

Results

None of the evaluated static or temporal parameters allowed discrimination between high and low grade tumours. On average, low grade tumours showed washout after the initial uptake maximum, while both increases and decreases were seen for high grade tumours. Only the relative early versus late uptake ratio showed a trend towards significance (−0.16 ± 0.17 for low grade versus 0.01 ± 0.25 for high grade; p = 0.07).

Conclusion

Unlike FET–PET, the uptake characteristics of MET-PET do not allow classification of low and high grade tumours on an individual patient basis. Since literature data indicate that both tracers have a similar performance regarding biopsy location, tumour delineation, and detection of recurrence, FET–PET should be advocated over MET–PET as its uptake mechanism also allows noninvasive grading in glioma.
Literatur
1.
Zurück zum Zitat Stupp R, Hegi ME, van den Bent MJ, et al. Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 2006;11:165–80.PubMedCrossRef Stupp R, Hegi ME, van den Bent MJ, et al. Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 2006;11:165–80.PubMedCrossRef
2.
Zurück zum Zitat Riemann B, Papke K, Hoess N, et al. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology 2002;225:567–74.PubMedCrossRef Riemann B, Papke K, Hoess N, et al. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology 2002;225:567–74.PubMedCrossRef
3.
4.
Zurück zum Zitat Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432–45.PubMed Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432–45.PubMed
5.
Zurück zum Zitat Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 2006;27:1432–37.PubMed Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L. [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 2006;27:1432–37.PubMed
6.
Zurück zum Zitat Weber WA, Dick S, Reidl G, et al. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001;42:1144–150.PubMed Weber WA, Dick S, Reidl G, et al. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001;42:1144–150.PubMed
7.
Zurück zum Zitat Popperl G, Kreth FW, Herms J, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 2006;47:393–403.PubMed Popperl G, Kreth FW, Herms J, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med 2006;47:393–403.PubMed
8.
Zurück zum Zitat Weckesser M, Langen KJ, Rickert CH, et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005;32:422–9.PubMedCrossRef Weckesser M, Langen KJ, Rickert CH, et al. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging 2005;32:422–9.PubMedCrossRef
9.
Zurück zum Zitat Meier C, Ristic Z, Klauser S, Verrey F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J 2002;21:580–9.PubMedCrossRef Meier C, Ristic Z, Klauser S, Verrey F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J 2002;21:580–9.PubMedCrossRef
10.
Zurück zum Zitat Stober B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 2006;33:932–9.PubMedCrossRef Stober B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 2006;33:932–9.PubMedCrossRef
11.
Zurück zum Zitat Wester HJ, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999;40:205–12.PubMed Wester HJ, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999;40:205–12.PubMed
Metadaten
Titel
Non-invasive grading of brain tumours using dynamic amino acid PET imaging : does it work for 11C-Methionine?
verfasst von
Gérard Moulin-Romsée
Eduard D’Hondt
Tjibbe de Groot
Jan Goffin
Raf Sciot
Luc Mortelmans
Johan Menten
Guy Bormans
Koen Van Laere
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0557-4

Weitere Artikel der Ausgabe 12/2007

European Journal of Nuclear Medicine and Molecular Imaging 12/2007 Zur Ausgabe